Header image

Emerging diagnostic technology, a flavour of what’s coming

Tracks
Concurrent Stream 2
Thursday, May 8, 2025
1:20 PM - 2:05 PM
C2.5 & C2.6

Details

The COVID-19 pandemic became a watershed for diagnostics when the world turned to the sector to deliver the tools required to manage the crisis. It did streamline regulatory processes and accelerate the application of technologies. Some of these changes have stayed with us, others not. This session will showcase some of the latest advancements in diagnostic technology and explore how these innovations are poised to revolutionise patient care. We will also investigate the hurdles companies need to jump to get their products regulatory cleared, reimbursed and accepted in the market. Attendees will gain key insights into the future of diagnostics and the emerging trends shaping this fast-evolving field.


Speaker

Mr Peter Bradley
Principal
Qatalyst

Chair

Dr Scott Grist
Director
Gnomix

Panellist

Agenda Item Image
Dr. Michelle Hill
Founder
ProSeek Bio Pty Ltd

Panellist

Agenda Item Image
Mr John Kelly
Founder, Managing Director & CEO
Atomo Diagnostics

Panellist

Agenda Item Image
A/Prof. Alison Todd
Chief Scientific Officer & Founder
SpeeDx Pty Ltd

Panellist

loading